InvestorsHub Logo
Followers 63
Posts 7608
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Thursday, 08/21/2014 7:24:19 PM

Thursday, August 21, 2014 7:24:19 PM

Post# of 429025
Kowa could be waiting for good news on the Anchor designation and expansion of the market for Vascepa. If they get it, they may move ahead with a closer relationship with Amarin which would, among other things, involve enough funding to absolutely insure the completion of R-IT.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News